{"id":"CHEMBL1066","canonicalSmiles":"COc1cccc([C@@]2(O)CCCC[C@@H]2CN(C)C)c1","inchiKey":"TVYLLZQTGLZFBW-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R,R)-TRAMADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rel-Tramadol"],"crossReferences":{"PubChem":["144205141","170464654","26663897","29215256","29215258"],"Wikipedia":["Tramadol"],"drugbank":["DB00193"],"chEBI":["75725"]},"childChemblIds":["CHEMBL1200336","CHEMBL201531","CHEMBL438627","CHEMBL379021"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL116018","canonicalSmiles":"O=C(NO)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"JJQQOJRGUHNREK-PWNYCUMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL116018","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04496"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1172","canonicalSmiles":"Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1","inchiKey":"JAUOIFJMECXRGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESLORATADINE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerius","Clarinex","Desloratadine","Midetorin","Neoclarityn"],"synonyms":["Allex","Azomyr","Dasselta","Denosin","Descarboethoxyloratadine","Desloratadine","Desloratadine actavis","Desloratadine teva","Loratadine related compound a","Loratadine related compound a rs","NSC-759824","Opulis","SCH 34117","SCH-34117"],"crossReferences":{"DailyMed":["desloratadine"],"PubChem":["144205127","14742700","170464781","26719697","26754458","29215232","50086379"],"Wikipedia":["Desloratadine"],"drugbank":["DB00967"],"chEBI":["291342"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","HP_0000989","HP_0000964","MONDO_0005271","EFO_0000274","EFO_0003060","EFO_0007214","EFO_0005531","Orphanet_79292","MONDO_0002406","EFO_1001871","EFO_0007141","EFO_1001417","EFO_0003956"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL1194","canonicalSmiles":"CCCNC(C)C(=O)Nc1ccccc1C","inchiKey":"MVFGUOIZUNYYSO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRILOCAINE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ASTRA-1512","ASTRA-1515","Citanest","NSC-40027","Prilocaine","Propitocaine"],"crossReferences":{"DailyMed":["prilocaine","prilocaine%20hydrochloride"],"PubChem":["90341069"],"Wikipedia":["Prilocaine"],"drugbank":["DB00750"],"chEBI":["8404"]},"childChemblIds":["CHEMBL1200586"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000153253","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000196876"],"count":10},"linkedDiseases":{"rows":["MONDO_0041052","HP_0012532","EFO_0007202","EFO_0000701","EFO_0004616","EFO_0000707","EFO_0003843","HP_0000023","MONDO_0002635","EFO_0002496","EFO_0002950"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and is indicated for pain and has 5 investigational indications."}
{"id":"CHEMBL1200351","canonicalSmiles":"Nc1ccc(S(=O)(=O)[N-]c2ncccn2)cc1.[Na+]","inchiKey":"JLDCNMJPBBKAHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFADIAZINE SODIUM","yearOfFirstApproval":1941,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL439","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sulfadiazine sodium"],"synonyms":["NSC-117870","Sodium sulfadiazine","Sulfadiazine sodium"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1941 and is indicated for malaria."}
{"id":"CHEMBL1200490","canonicalSmiles":"CC(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H](Cc1cccnc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O","inchiKey":"SBNPWPIBESPSIF-MHWMIDJBSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CETRORELIX","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cetrotide"],"synonyms":["Cetrorelix"],"crossReferences":{"DailyMed":["cetrorelix"],"Wikipedia":["Cetrorelix"],"drugbank":["DB00050"],"chEBI":["59224"]},"childChemblIds":["CHEMBL2103735"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","Orphanet_64739","EFO_0000545","EFO_0000731","EFO_0001065","HP_0000138","EFO_0000284","EFO_0000660"],"count":8},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2000 and has 7 investigational indications."}
{"id":"CHEMBL1200608","canonicalSmiles":"CCCCC(CC)COC(=O)/C=C/c1ccc(OC)cc1","inchiKey":"YBGZDTIWKVFICR-JLHYYAGUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTINOXATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212893","29216315"],"Wikipedia":["Octyl_methoxycinnamate"],"drugbank":["DB09496"],"chEBI":["88667"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200642","drugType":"Protein","blackBoxWarning":false,"name":"INDIUM IN 111 PENTETREOTIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110556","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Octreoscan"],"synonyms":["(sup 111)indium pentetreotide","111indium pentetreotide","Indium (111 in) pentetreotide","Indium (111in) pentetreotide","Indium in 111 pentetreotide","Indium in-111 pentetreotide","Indium in-111 pentetreotide kit","Indium-111 pentetreotide","MP-1727","Pentetreotide 111in chelate"],"crossReferences":{"DailyMed":["indium%20in-111%20pentetreotide%20kit"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1994."}
{"id":"CHEMBL1200782","canonicalSmiles":"C[C@H](N)Cc1ccccc1.O=C(O)CCCCC(=O)O","inchiKey":"OFCJKOOVFDGTLY-QRPNPIFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROAMPHETAMINE ADIPATE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL612","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["D-amphetamine adipate","Dextroamphetamine adipate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975."}
{"id":"CHEMBL1200978","canonicalSmiles":"O=[As]O[As]=O","inchiKey":"IKWTVSLWAPBBKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARSENIC TRIOXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Trisenox"],"synonyms":["Arsenic trioxide"],"crossReferences":{"PubChem":["26758061"],"Wikipedia":["Arsenic_trioxide"],"drugbank":["DB01169"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201118","canonicalSmiles":"CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)[O-])=C(CSc3nnnn3C)CS[C@@H]21.[Na+]","inchiKey":"BITQGIOJQWZUPL-PBCQUBLHSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFMETAZOLE SODIUM","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201195","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Zefazone"],"synonyms":["Cefmetazole sodium","Cefmetazole sodium salt","NSC-758171","U-72791A"],"crossReferences":{"PubChem":["170465052","50106019","855824"],"chEBI":["3490"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989 and has 1 investigational indication."}
{"id":"CHEMBL1201236","canonicalSmiles":"C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O","inchiKey":"TZFNLOMSOLWIDK-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBIDOPA","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lodosyn"],"synonyms":["Carbidopa"],"crossReferences":{"DailyMed":["carbidopa"],"PubChem":["11113507","144204461","26749935","29215028","50104417","50104418","8139862","93576631"],"Wikipedia":["Carbidopa"],"drugbank":["DB00190"],"chEBI":["39585"]},"childChemblIds":["CHEMBL1200748"],"linkedTargets":{"rows":["ENSG00000132437"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0002610","EFO_0005687","EFO_0001365","EFO_1000809","EFO_0005252","EFO_1001919","EFO_0003768","Orphanet_72","Orphanet_1764","MONDO_0002050","MONDO_0005180","EFO_0000712","EFO_1001402","MONDO_0001162","MONDO_0004976","EFO_0003888","HP_0012532","EFO_0004329","MONDO_0001020","EFO_0003770","Orphanet_55","HP_0002381","HP_0003418","EFO_0003843","EFO_0000537","Orphanet_791","EFO_0000546","EFO_1001175","MONDO_0005301","MONDO_0004979"],"count":31},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 4 approved and 21 investigational indications."}
{"id":"CHEMBL1201325","canonicalSmiles":"C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1","inchiKey":"ZRYHPQCHHOKSMD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HEXOCYCLIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hexocyclium","Hexocyclium cation","Hexocyclium ion"],"crossReferences":{"Wikipedia":["Hexocyclium"],"drugbank":["DB06787"],"chEBI":["5707"]},"childChemblIds":["CHEMBL1626570"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201458","drugType":"Small molecule","blackBoxWarning":true,"name":"ETHIODIZED OIL","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ethiodol","Lipiodol"],"synonyms":["Ethiodized oil"],"crossReferences":{"DailyMed":["ethiodized%20oil"],"Wikipedia":["Lipiodol"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and is indicated for neoplasm and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201608","drugType":"Antibody","blackBoxWarning":true,"name":"MUROMONAB-CD3","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orthoclone okt3"],"synonyms":["Anticd3","L04AA02","Macs gmp cd3 pure","Muromomab","Muromonab","Muromonab cd3","Muromonab-cd3","OKT-3","OKT3"],"crossReferences":{"DrugCentral":["5177"],"Wikipedia":["Muromonab-CD3"]},"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000729","EFO_0003865","EFO_0000756","EFO_0000389","EFO_1001249","MONDO_0002367","EFO_0000540","EFO_1000158","EFO_0000311"],"count":10},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for immune system disease and has 9 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201759","canonicalSmiles":"O=C(O)CCCN1CCC(O[C@@H](c2ccc(Cl)cc2)c2ccccn2)CC1.O=S(=O)(O)c1ccccc1","inchiKey":"UDGHXQPQKQPSBB-BOXHHOBZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEPOTASTINE BESYLATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201758","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bepreve"],"synonyms":["BB","Bepotastine Besilate","Bepotastine benzenesulfonate salt","Bepotastine besilate","Bepotastine besylate","TAU-284","Talion"],"crossReferences":{"DailyMed":["bepotastine%20besilate"],"chEBI":["31281"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0005271","EFO_0007141","EFO_1001417"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for pruritus and allergic conjunctivitis and has 1 investigational indication."}
{"id":"CHEMBL1230661","canonicalSmiles":"CN[C@@H](C)C(=O)N[C@H](C(=O)N1C[C@@H](Oc2ccccc2)C[C@H]1C(=O)N[C@@H]1CCCc2ccccc21)C(C)(C)C","inchiKey":"QKPXPZYQPBWDHS-MCJAPYMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1230661","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04612"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232920","canonicalSmiles":"O=P(O)(O)OC[C@H](O)CO","inchiKey":"AWUCVROLDVIAJX-GSVOUGTGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232920","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29218087"],"drugbank":["DB02515"],"chEBI":["15978"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232997","canonicalSmiles":"N[C@@H](CCC(=O)N[C@@H](CSc1ccc([N+](=O)[O-])cc1[N+](=O)[O-])C(=O)NCC(=O)O)C(=O)O","inchiKey":"FXEUKVKGTKDDIQ-UWVGGRQHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232997","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02458"],"chEBI":["8927"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233636","canonicalSmiles":"O=S(=O)(O)Oc1c[nH]c2ccccc12","inchiKey":"BXFFHSIDQOFMLE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOXYL SULFATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07992"],"chEBI":["43355"]},"childChemblIds":["CHEMBL1452061"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234254","canonicalSmiles":"Cc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1","inchiKey":"SJXRKKYXNZWKDB-DJLDLDEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234254","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03735"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235259","canonicalSmiles":"OCCOCCOCCO","inchiKey":"ZIBGPFATKBEMQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIETHYLENE GLYCOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205626","144209638","144210626","26757203","26757204"],"drugbank":["DB02327"],"chEBI":["44926"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236200","canonicalSmiles":"CC(C)(C)OC=O","inchiKey":"RUPAXCPQAAOIPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERT-BUTYL FORMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207557","17388715"],"drugbank":["DB02768"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL129","canonicalSmiles":"Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O","inchiKey":"HBOMLICNUCNMMY-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ZIDOVUDINE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["AZT","Azidothymidine","Retrovir","Zidovudine"],"synonyms":["3'-azt","AZT","Azidothymidine","BW A509U","BW-A-509U","BW-A509U","BWA509U","COMPOUND S","COMPOUND-S","NSC-602670","Retrovir","Zidovudine","Zidovudinum"],"crossReferences":{"DailyMed":["zidovudine"],"PubChem":["144203613","144204445","144209401","144210895","170464737","17390027","26751584","49718184","855980","90341185"],"Wikipedia":["Zidovudine"],"drugbank":["DB00495"],"chEBI":["10110"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 4 approved and 17 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1295","canonicalSmiles":"Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1","inchiKey":"SWLMUYACZKCSHZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTOCONAZOLE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Butoconazole","Gynazole-1","Gynofort","NSC-758658"],"crossReferences":{"Wikipedia":["Butoconazole"],"drugbank":["DB00639"],"chEBI":["3240"]},"childChemblIds":["CHEMBL1200398"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL131921","canonicalSmiles":"COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1","inchiKey":"WUADCCWRTIWANL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIOCHANIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-123538"],"crossReferences":{"PubChem":["11113288","124883150","124883151","144209295","144213218","174007208","26746976","26751494","416963","50100559","50104034","50123128","56422868","855738"],"Wikipedia":["Biochanin_A"],"drugbank":["DB15334"],"chEBI":["17574"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1373254","canonicalSmiles":"NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O","inchiKey":"BKYKPTRYDKTTJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOPENTHIAZIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Navidrex"],"synonyms":["Cyclopenthiazide","NSC-107679","SU-8341"],"crossReferences":{"PubChem":["170466046","26664668"],"drugbank":["DB13532"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL147507","canonicalSmiles":"Cc1cccc(C)c1OC[C@@H](C)N","inchiKey":"VLPIATFUUWWMKC-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-MEXILETINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["mexiletine"],"crossReferences":{"drugbank":["DB07129"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1476782","canonicalSmiles":"COc1ccc(/C=C/C(=O)OCCC(C)C)cc1","inchiKey":"UBNYRXMKIIGMKK-RMKNXTFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMILOXATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amiloxate","E-1000","Isoamyl methoxycinnamate","Isoamyl p-methoxycinnamate","NSC-408332"],"crossReferences":{"PubChem":["29215376"],"drugbank":["DB11207"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1571863","canonicalSmiles":"Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1","inchiKey":"MPIPASJGOJYODL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOCONAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Travogyn"],"synonyms":["Isoconazole","Isoconazole nitrate","R 15,454","R-15,454","R-15,454 [AS NITRATE SALT]","R-15454"],"crossReferences":{"PubChem":["144204167","170466012","56463710"],"drugbank":["DB08943"],"chEBI":["83667"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1740065","canonicalSmiles":"CCC(C)(CN(C)C)OC(=O)c1ccccc1","inchiKey":"FDMBBCOBEAVDAO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMYLOCAINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amylocaine"],"crossReferences":{"drugbank":["DB09088"],"chEBI":["34981"]},"childChemblIds":["CHEMBL1718204"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1743055","drugType":"Antibody","blackBoxWarning":false,"name":"PANOBACUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AERUMAB 11","Panobacumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1770248","canonicalSmiles":"CCOc1ccc(Cc2cc([C@]34OC[C@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1","inchiKey":"MCIACXAZCBVDEE-CUUWFGFTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERTUGLIFLOZIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Steglatro"],"synonyms":["Ertugliflozin","PF-04971729","PF-04971729-00","PF04971729","Pf-04971729"],"crossReferences":{"DailyMed":["ertugliflozin"],"drugbank":["DB11827"]},"childChemblIds":["CHEMBL3526992"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0003144","MONDO_0005148","EFO_0000400"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for type 2 diabetes mellitus and diabetes mellitus and has 1 investigational indication."}
{"id":"CHEMBL178459","canonicalSmiles":"Cc1c(-c2cnccn2)ssc1=S","inchiKey":"CKNAQFVBEHDJQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLTIPRAZ","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-347901","Oltipraz"],"crossReferences":{"PubChem":["462739"],"Wikipedia":["Oltipraz"],"drugbank":["DB12539"],"chEBI":["77319"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1828820","canonicalSmiles":"c1cc([C@H]2CC[C@]3(CC2)OO[C@]2(O3)C3CC4CC(C3)CC2C4)ccc1OCCN1CCOCC1","inchiKey":"XLCNVWUKICLURR-NTNLSYPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEFENOMEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Artefenomel","OZ-439","OZ439","Oz439"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL189434","canonicalSmiles":"OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12","inchiKey":"UQHINZSKNAAVOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL189434","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08393"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL190412","canonicalSmiles":"COCCOCCOCCOCCOC(=O)OC[n+]1ccc(N/C(=N/CCCCCCOc2ccc(Cl)cc2)NC#N)cc1.[Cl-]","inchiKey":"DAHMXVAETAAQOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEGLARINAD CHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1181731","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EB-1627","EB1627","GMX-1777","GMX1777","Teglarinad chloride"],"linkedTargets":{"rows":["ENSG00000105835"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL191482","canonicalSmiles":"CC(C)[C@H](C(=O)Nc1ccc(C(=O)NO)cc1)c1ccccc1","inchiKey":"LAMIXXKAWNLXOC-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AR-42","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-HDAC 42","(S)-HDAC-42","AR-42","AR42","Ar-42","Osu-hdac 42","Rec-2282"],"crossReferences":{"drugbank":["DB12707"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL194176","canonicalSmiles":"CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1","inchiKey":"HTIZPBXCJPQDEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL194176","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07334"]},"childChemblIds":["CHEMBL193849"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL200528","canonicalSmiles":"CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1","inchiKey":"IVUBNTNWKIPCPS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL200528","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04715"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2017974","canonicalSmiles":"Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1","inchiKey":"CWHUFRVAEUJCEF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUPARLISIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BKM-120","BKM-120NX","BKM120-NX","Bkm-120","Buparlisib","NVP-BKM-120","NVP-BKM120"],"crossReferences":{"PubChem":["137275918"],"drugbank":["DB11666"],"chEBI":["71954"]},"childChemblIds":["CHEMBL2364604"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003869","MONDO_0044903","EFO_0000756","MONDO_0007254","EFO_1001469","EFO_1001951","EFO_0000565","EFO_1001480","MONDO_0002974","MONDO_0008903","EFO_0000616","EFO_0006859","MONDO_0002108","Orphanet_44890","EFO_0000403","MONDO_0007576","EFO_0003060","MONDO_0008315","EFO_1000581","EFO_0000095","MONDO_0011962","EFO_0001421","EFO_0000702","EFO_0006544","MONDO_0018906","EFO_0000519","EFO_0000181"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 26 investigational indications."}
{"id":"CHEMBL2103825","canonicalSmiles":"CCCCCCCCCCCCCCCCOc1nc2ccc(C)cc2c(=O)o1","inchiKey":"MVCQKIKWYUURMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETILISTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATL-962","Cetilistat"],"crossReferences":{"drugbank":["DB06586"]},"linkedTargets":{"rows":["ENSG00000175535","ENSG00000182333"],"count":2},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104168","canonicalSmiles":"CCC(=O)O[C@]1(c2ccccc2)CCN(C)C[C@H]1CC","inchiKey":"ODEGQXRCQDVXSJ-RHSMWYFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAMEPRODINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Betameprodine","IDS-NB-004","NU-1932"],"crossReferences":{"drugbank":["DB01552"]},"childChemblIds":["CHEMBL3246684"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104988","canonicalSmiles":"CCCc1c(SCCCOc2ccc(C(C)=O)c(OCCCC(=O)O)c2CCC)ccc(C(C)=O)c1O","inchiKey":"KPWYNAGOBXLMSE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIPELUKAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KCA-757","MN-001","Tipelukast"],"crossReferences":{"drugbank":["DB12435"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105291","canonicalSmiles":"C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CC=C4C=C(OC5CCCC5)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"FLGJKPPXEKYCBY-AKCFYGDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"QUINGESTANOL ACETATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Quingestanol","Quingestanol acetate","W 4540","W-4540"],"crossReferences":{"drugbank":["DB14679"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105741","canonicalSmiles":"CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1.C[S+](C)[O-]","inchiKey":"OQUFJVRYDFIQBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAMETINIB DIMETHYL SULFOXIDE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mekinist"],"synonyms":["GSK-1120212B","GSK1120212B","Trametinib dimethyl sulfoxide"],"crossReferences":{"DailyMed":["trametinib%20dimethyl%20sulfoxide"],"chEBI":["75991"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["MONDO_0002108","EFO_0000389","MONDO_0008903","EFO_1000926","EFO_0001378","EFO_0002617","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL2105953","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(Cn3nnc(C)n3)CS[C@H]12)c1csc(N)n1","inchiKey":"XSPUSVIQHBDITA-RKYNPMAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTERAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefteram","Cefteram pivoxil","RO 19-5247"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106825","canonicalSmiles":"CC(=O)[C@@]1(C)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"HCFSGRMEEXUOSS-JXEXPEPMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEDROGESTONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Colpro"],"synonyms":["AY 62022","AY-13615","AY-13615S","AY-62022","Colprone","Etogyn","Medrogesterone","Medrogestone","Metrogestone","NSC-123018","Prothil"],"crossReferences":{"drugbank":["DB09124"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107583","canonicalSmiles":"O=[N+]([O-])OC[C@H](O[N+](=O)[O-])[C@@H](CO[N+](=O)[O-])O[N+](=O)[O-]","inchiKey":"SNFOERUNNSHUGP-ZXZARUISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERYTHRITYL TETRANITRATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Cardilate"],"synonyms":["C01DA13","Eritrityl tetranitrate","Erythritol tetranitrate","Erythrityl tetranitrate","Erythrol tetranitrate","Meso-erythritol tetranitrate","NSC-106566","Nitroerythrol","Tetranitrol"],"crossReferences":{"drugbank":["DB01613"],"chEBI":["60072"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2108292","drugType":"Protein","blackBoxWarning":false,"name":"EPTACOG ALFA PEGOL (ACTIVATED)","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Activated recombinant human factor vii, long acting","Eptacog alfa pegol (activated)"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108609","drugType":"Unknown","blackBoxWarning":false,"name":"INALIMAREV (CEA, MUC-1, VACCINIA VIRUS)","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Panvac"],"synonyms":["Inalimarev (cea, muc-1, vaccinia virus)"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2108720","drugType":"Antibody","blackBoxWarning":false,"name":"OXELUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CD-252","CD252","Glycoprotein gp34","HUMAB OX-40L","HUMAB OX40L","Humab ox 40l","OX-40L","OX40L","Ox40 ligand","Oxelumab","R-4930","R-4930 HUMAB OX40L","R-4930 HUMABOX40L","R4930","RO-49-89991","RO-4989991","RO4989991"],"linkedTargets":{"rows":["ENSG00000117586"],"count":1},"linkedDiseases":{"rows":["MONDO_0004979"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109016","drugType":"Unknown","blackBoxWarning":false,"name":"ALUMINUM CHLOROHYDRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hyperdrol"],"synonyms":["Alchlordrate","Aluminium chlorohydrate","Aluminum chlorhydrate","Aluminum chlorhydroxide","Aluminum chlorohydrate","Aluminum hydroxychloride","Chlorhydrol","DA-1097","Locron","Oristar alch","Pac 1000","Phosphonorm","Reach 101","Reach 103","Reach 501","Sumalchlor 50","Takibine 1500"],"crossReferences":{"DrugCentral":["4495"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved indications."}
{"id":"CHEMBL2109152","drugType":"Small molecule","blackBoxWarning":false,"name":"MINERAL OIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alpha keri","Ashbourne emollient","Aveeno","Balneol","Dermalo","Doublebase","Emmolate","Emulsiderm","Gppe emollient","Lacri-lube","Liq paraf light","Lubri-tears","Neo-cultol","Nujol","Oilatum jnr","Petrolagar","Rae's","Zerolatum","Zerolatum plus"],"synonyms":["E-905D","Heavy liquid petrolatum","INS NO.905D","INS-905D","Liquid paraffin","Liquid petrolatum","Mineral oil","Mineral oil, heavy","Mineral oil,heavy","Mineral oil,refined","Paraffin, liquid","Paraffinum liquidum","Petrolatum, liquid"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation disorder and constipation and has 1 investigational indication."}
{"id":"CHEMBL2109467","drugType":"Antibody","blackBoxWarning":false,"name":"ORDESEKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 714","AMG-714","AMG714","Amg 714","Amg-714","Humax il15","Humax-il 15","Ordesekimab","PRV-015","Prv-015"],"linkedTargets":{"rows":["ENSG00000164136"],"count":1},"linkedDiseases":{"rows":["EFO_0001060","EFO_0000685","EFO_0000676","EFO_0004208"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109485","drugType":"Antibody","blackBoxWarning":false,"name":"ONCOLYSIN CD6","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ONCOLYSIN CD6"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2110731","canonicalSmiles":"CCc1ccc(Cc2ccc3c(c2)[C@]2(OC3)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc1","inchiKey":"VWVKUNOPTJGDOB-BDHVOXNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOFOGLIFLOZIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tofogliflozin"],"crossReferences":{"drugbank":["DB11824"]},"childChemblIds":["CHEMBL2105711"],"linkedTargets":{"rows":["ENSG00000140675"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL223402","canonicalSmiles":"O=C(Nc1ccccc1F)N[C@H]1N=C(c2ccccc2)c2ccccc2NC1=O","inchiKey":"MTPVBMVUENFFLL-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RSV-604","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-60444","RSV 604","RSV-604","RSV604","Rsv-604","Rsv604"],"crossReferences":{"drugbank":["DB15197"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2386889","canonicalSmiles":"Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1","inchiKey":"GMIZZEXBPRLVIV-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SCH-900776","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8776","Mk-8776","SCH 900776","SCH-900776","Sch-900776"],"crossReferences":{"drugbank":["DB11899"]},"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000339","EFO_0000220","EFO_0000222","EFO_0000183","EFO_0005952"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL249334","canonicalSmiles":"Cc1ccccc1-c1cc(NCc2ccc[n+]([O-])c2)n2ncc(Br)c2n1","inchiKey":"DXUJQXZHHGJMFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL249334","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07179"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255874","canonicalSmiles":"Clc1ccc2c(c1Nc1ccnc(Nc3cccc(N4CCOCC4)c3)n1)OCO2","inchiKey":"PNEWIQAEGKQNCE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL255874","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL258467","canonicalSmiles":"Cc1cc(-c2csc(Nc3ccc(C(=O)O)c(O)c3)n2)ccc1F","inchiKey":"LKZZDHKJFDTYCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL258467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07616"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278519","canonicalSmiles":"O=C1c2ccccc2C(=O)C1c1ccc(Cl)cc1","inchiKey":"NJDUWAXIURWWLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORINDIONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(p-chlorophenyl)-1,3-indandion","Chlophenadione","Chlorphenindione","Chlorphenylindandione","Clorindione","G-25766","NSC-758878"],"crossReferences":{"PubChem":["144205450","29216241","50085911"],"Wikipedia":["Clorindione"],"drugbank":["DB13275"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL289480","canonicalSmiles":"C1COC(NC(C2CC2)C2CC2)=N1","inchiKey":"CQXADFVORZEARL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILMENIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hyperium","Rilmenidine"],"crossReferences":{"PubChem":["104171229","11111726","11111727","11113329","124881316","144203805","170466278","50103956","510678","85231209","90340708"],"Wikipedia":["Rilmenidine"],"drugbank":["DB11738"],"chEBI":["8862"]},"childChemblIds":["CHEMBL1256674"],"linkedTargets":{"rows":["ENSG00000010322"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL301769","canonicalSmiles":"Nc1nc(N)c2nc(CN3c4ccccc4C=Cc4ccccc43)cnc2n1","inchiKey":"NXCCIJQEAKMFGW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL301769","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08406"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL305178","canonicalSmiles":"C[C@H](Nc1nccc(-c2c(-c3cccc(C(F)(F)F)c3)nc(C3CCNCC3)n2C)n1)c1ccccc1","inchiKey":"QICPQLFMWYQJGX-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL305178","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01761"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3137303","canonicalSmiles":"COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(OP(=O)([O-])[O-])c2)c(OC)c1.[Na+].[Na+]","inchiKey":"MIBWXNAYNGADJD-MIIBGCIDSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"BRICICLIB SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1206245","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Briciclib sodium","ON 013105"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL318721","canonicalSmiles":"CCC(CC)n1ccc2c3c(N)nc(N)nc3ccc21","inchiKey":"GCPJCLJGTVTGRF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL318721","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07862"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL332750","canonicalSmiles":"CCOc1ccc(-c2nc(-c3cccc(C(=O)O)n3)cs2)cc1OCC","inchiKey":"XDBHURGONHZNJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETOMILAST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OPC-6535","Tetomilast"],"crossReferences":{"drugbank":["DB05298"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000341","EFO_0000384"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL33720","canonicalSmiles":"CNCC(O)c1ccc(O)cc1","inchiKey":"YRCWQPVGYLYSOX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXEDRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Advantra z","Analeptin","Dl-synephrine","Ethaphene","NSC-166285","NSC-170956","Oxedrine","P-synephrine","Parasympatol","S-38537-9","Simpalon","Synephrin","Synephrine","Synthenate"],"crossReferences":{"PubChem":["144203941","144208160","170466681","17388717","174007352","49681813","50105255","85231217","855689","90340909"],"Wikipedia":["Synephrine"],"drugbank":["DB09203"],"chEBI":["29081"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL345714","canonicalSmiles":"Cc1cnc(C(=O)O)c[n+]1[O-]","inchiKey":"DJQOOSBJCLSSEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACIPIMOX","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Olbetam"],"synonyms":["Acipimox","NSC-759818"],"crossReferences":{"PubChem":["144205421","144206051","144206358","50110108"],"Wikipedia":["Acipimox"],"drugbank":["DB09055"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3544952","drugType":"Small molecule","blackBoxWarning":false,"name":"RG3487","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Facinicline hydrochloride","MEM 3454","MEM-3454","MEM3454","RG-3487","RG3487","Rg3487"],"linkedTargets":{"rows":["ENSG00000175344","ENSG00000149305","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736"],"count":6},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3544989","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"VOLANESORSEN SODIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 304801","ISIS 304801 SODIUM SALT","ISIS-304801 SODIUM","ISIS-304801 SODIUM SALT","Volanesorsen sodium","salt"],"linkedTargets":{"rows":["ENSG00000110245"],"count":1},"linkedDiseases":{"rows":["EFO_1000727"],"count":1},"description":"Oligonucleotide drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545007","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7602","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0425","RG-7602","Rg-7602"],"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL354634","canonicalSmiles":"COc1cc[nH]c1/C=C1\\C(=O)Nc2ccc(F)c(C#C[C@@H](O)[C@@H](N)[C@@H](C)O)c21","inchiKey":"RAKYKJWUUUKCCW-MPLBGYFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL354634","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03737"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL373742","canonicalSmiles":"N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"KBZOIRJILGZLEJ-LGYYRGKSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VASOPRESSIN","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Beta-Hypophamine","Leiormone","Pitressin","Vasophysin","Vasostrict"],"synonyms":["Arginine Vasopressin","Arginine vasopressin","Argipressin or lypressin","Vasopressin","Vasopressin injection","Vasopressin, unspecified"],"crossReferences":{"DailyMed":["vasopressin"],"PubChem":["144206588","29218064"],"chEBI":["34543"]},"childChemblIds":["CHEMBL2360839"],"linkedTargets":{"rows":["ENSG00000126895","ENSG00000166148","ENSG00000198049"],"count":3},"linkedDiseases":{"rows":["EFO_0004610","EFO_0003756","MONDO_0005149","EFO_0003777","EFO_0006834","MONDO_0002009","HP_0001919","EFO_0005207","EFO_0004278","MONDO_0003061","EFO_0003758","EFO_0003843","HP_0100806","MP_0001914","MONDO_0004782","MONDO_0001572","HP_0003270","HP_0031273","EFO_0009492","EFO_0009637","EFO_0005251"],"count":21},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for diabetes insipidus and sepsis and has 16 investigational indications."}
{"id":"CHEMBL376632","canonicalSmiles":"Cc1cc(N2CCC[C@@H]2C(=O)NCCc2ccc3c(c2)OCO3)nc(-n2ccnc2)n1","inchiKey":"LBCGUKCXRVUULK-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL376632","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06916"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3769414","canonicalSmiles":"CN1C(=O)c2c(nn(Cc3ccc(-c4cccc(F)n4)cc3)c2Nc2ccccc2)N2C1=N[C@@H]1CCC[C@@H]12","inchiKey":"BBIPVJCGIASXJB-PKTZIBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LENRISPODUN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IC-200214","IC200214","ITI-214","ITI-214F","Iti-214","Iti-214 free base","Lenrispodun"],"crossReferences":{"drugbank":["DB15039"]},"childChemblIds":["CHEMBL3770459"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL398338","canonicalSmiles":"CC(C)(C)c1ccc2c(c1)CC[C@H]2NC(=O)Nc1cccc2[nH]ncc12","inchiKey":"TYOYXJNGINZFET-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-102","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-102","Abt-102"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989566","canonicalSmiles":"COCCc1ccc(OCC(O)CNC(C)C)cc1.COCCc1ccc(OCC(O)CNC(C)C)cc1.O=C(O)/C=C/C(=O)O","inchiKey":"BRIPGNJWPCKDQZ-WXXKFALUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METOPROLOL FUMARATE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL13","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lopressor","Metoros","Metoros ls"],"synonyms":["CGP 2175C","CGP-2175C","Metoprolol fumarate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1989."}
{"id":"CHEMBL3991932","canonicalSmiles":"Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1","inchiKey":"LNMRSSIMGCDUTP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PEXMETINIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ARRY-614","Arry-614","Pexmetinib"],"linkedTargets":{"rows":["ENSG00000112062","ENSG00000120156"],"count":2},"linkedDiseases":{"rows":["EFO_0000198"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4094396","canonicalSmiles":"CNC(C)C(=O)c1ccc(C)cc1","inchiKey":"YELGFTGWJGBAQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHEDRONE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-methylephedrone","4-methylmethcathinone","4-mmc","J2.756.280I","M-cat","Meow meow","Mephedrone"],"crossReferences":{"drugbank":["DB13108"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL428593","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCC(=O)OCC(O)CO","inchiKey":"RZRNAYUHWVFMIP-KTKRTIGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYL MONOOLEATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-monoolein","1-mono(cis-9-octacenoyl)glycerol","1-monoolein","1-monooleoyl-rac-glycerol","FEMA NO. 2526","Glycerol 1-monooleate","Glycerol monooleate","Glyceryl 1-oleate","Glyceryl mono-oleate","Glyceryl monooleate","Glyceryl monooleate 40","Glyceryl monooleate 40%","Glyceryl monooleate 60","Glyceryl monooleate 90","Glyceryl monooleate 90%","Glyceryl oleate","Mono-olein","Monolein","Monoolein","NSC-406285","Olein","Rac-1-monooleoylglycerol"],"crossReferences":{"drugbank":["DB13171"],"chEBI":["75342"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297460","canonicalSmiles":"CCOc1cc([C@@H](CS(C)(=O)=O)N2Cc3cccc(NC(=O)C4CC4)c3C2=O)ccc1OC","inchiKey":"QDZOBXFRIVOQBR-LJQANCHMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CC-11050","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CC-11050","Cc-11050"],"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["EFO_0003834","Orphanet_3389"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297501","canonicalSmiles":"Cc1c(CN(C)C(=O)/C=C/c2cnc3c(c2)CCC(=O)N3COP(=O)(O)O)oc2ccccc12","inchiKey":"HFYMDQMXVPJNTH-VQHVLOKHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFABICIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afabicin"],"crossReferences":{"drugbank":["DB15268"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297537","drugType":"Oligonucleotide","blackBoxWarning":true,"name":"INOTERSEN SODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tegsedi"],"synonyms":["Inotersen sodium"],"crossReferences":{"DailyMed":["inotersen%20sodium"]},"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["EFO_0009562","EFO_1001875","Orphanet_85447"],"count":3},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 3 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297830","drugType":"Protein","blackBoxWarning":false,"name":"SOMATROGON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ctp-somatropin fusion protein","MOD-4023","MOD4023","Mod-4023","Somatrogon","Somatropin-ctp fusion protein"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297862","drugType":"Unknown","blackBoxWarning":true,"name":"BOTULINUM TOXIN TYPE A","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Agn-151607","Ant-1401","Ant-1403","Botulift","Botulinum a toxin","Botulinum toxin type a","Btx-a","Cunox","Neuronox","RTI-150","RTI150"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297958","drugType":"Protein","blackBoxWarning":false,"name":"GLUCAGON-LIKE PEPTIDE II","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-33-glucagon-like peptide ii","Glp-2","Glp-2 (1-33)","Glp-2 (human)","Glucagon-like peptide 2","Glucagon-like peptide ii"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298088","drugType":"Antibody","blackBoxWarning":false,"name":"CETUXIMAB SAROTALOCAN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-1929","Cetuximab sarotalocan","Cetuximab-IRDye-700DX","Cetuximab-irdye 700dx conjugate","RM-1929"],"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0006859"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4298119","drugType":"Antibody","blackBoxWarning":false,"name":"OLINVACIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Olinvacimab","TTAC-0001","Tanibirumab","Ttac-0001"],"linkedTargets":{"rows":["ENSG00000128052"],"count":1},"linkedDiseases":{"rows":["EFO_1001480","EFO_0005537","MONDO_0007254","MONDO_0024880","EFO_0000519"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4298191","drugType":"Antibody","blackBoxWarning":false,"name":"SASANLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06801591","RN-888","Sasanlimab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000673","EFO_0008528","EFO_0003060","MONDO_0001187","EFO_0009708"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL435128","canonicalSmiles":"CC(C)c1nc(COC(N)=O)n(Cc2ccncc2)c1Sc1cc(Cl)cc(Cl)c1","inchiKey":"YQXCVAGCMNFUMQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAPRAVIRINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Capravirine","S-1153"],"crossReferences":{"Wikipedia":["Capravirine"],"drugbank":["DB08502"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL447955","canonicalSmiles":"C[C@@H](O[C@H]1CC[C@@H]2CN(C3=CC(=O)CC3)C[C@H]2[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1","inchiKey":"FLNYCRJBCNNHRH-OIYLJQICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SERLOPITANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0594","Serlopitant","VPD-737","Vpd-737"],"crossReferences":{"drugbank":["DB12973"]},"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["HP_0000989","MONDO_0026045","EFO_1000690"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594309","drugType":"Gene","blackBoxWarning":false,"name":"ORVACABTAGENE AUTOLEUCEL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JCARH-125","JCARH125","Jcarh125","Orvacabtagene autoleucel"],"description":"Gene drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594565","drugType":"Protein","blackBoxWarning":false,"name":"PABINAFUSP ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["JR-141","Jr-141","Pabinafusp alfa"],"linkedTargets":{"rows":["ENSG00000072274","ENSG00000106327"],"count":2},"linkedDiseases":{"rows":["Orphanet_79213"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650298","drugType":"Unknown","blackBoxWarning":false,"name":"PLB1003","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLB1003","Plb1003"],"linkedTargets":{"rows":["ENSG00000171094","ENSG00000143924"],"count":2},"linkedDiseases":{"rows":["EFO_0003060"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650312","canonicalSmiles":"O=C(O)CCc1ccc(S(=O)(=O)CCc2c(CCNS(=O)(=O)Cc3ccccc3C(F)(F)F)n(C(c3ccccc3)c3ccccc3)c3ccc(Cl)cc23)cc1","inchiKey":"HWNIPKHEEVNHMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-5212372","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-05212372","PF-5212372","PLA-950","Pf-05212372","Pf-5212372","ZPL 5212372","ZPL-521","ZPL-5212372"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL466465","canonicalSmiles":"Cc1ccc(S(=O)(=O)N[C@@H](CCCCN)C(=O)CCl)cc1","inchiKey":"RDFCSSHDJSZMTQ-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Tosyl-L-Lysine Chloromethyl Ketone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tosyl-L-Lysine Chloromethyl Ketone"],"crossReferences":{"PubChem":["11111912","50111259"],"drugbank":["DB08603"],"chEBI":["9640"]},"childChemblIds":["CHEMBL1256974"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46730","canonicalSmiles":"c1ccc2c(c1)ccc1ccccc12","inchiKey":"YNPNZTXNASCQKK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENANTHRENE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-26256","Phenanthrene","Ravatite"],"crossReferences":{"PubChem":["144208836","144210890","17388787","26752927","85272564"],"chEBI":["28851"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL47298","canonicalSmiles":"CCN(CC)CCOc1ccc2c(c1)C(=O)c1cc(OCCN(CC)CC)ccc1-2","inchiKey":"MPMFCABZENCRHV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TILORONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amixin IC","Tilorone"],"crossReferences":{"PubChem":["144205037","170466150","26749100"],"Wikipedia":["Tilorone"]},"childChemblIds":["CHEMBL539581"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL477786","canonicalSmiles":"Cc1ncc(-c2ccnc(Nc3ccc(N4CCN(C(=O)CO)CC4)cc3)n2)n1C(C)C","inchiKey":"PVTKDXZNSUHUMO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL477786","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07982"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL483091","canonicalSmiles":"CC(C)SC(=N)N","inchiKey":"XSSNABKEYXKKMK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Isopropyl-Isothiourea","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Isopropyl-Isothiourea"],"crossReferences":{"PubChem":["11113769"],"drugbank":["DB04018"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489285","canonicalSmiles":"O=C(Nc1cc(Br)c(O)c(Br)c1)c1cc(Cl)ccc1Cl","inchiKey":"IFLWCZRMFPKYBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489285","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07694"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL50300","canonicalSmiles":"O=C(O)CP(=O)(O)O","inchiKey":"XUYJLQHKOGNDPB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFONET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosfonet","NSC-18205"],"crossReferences":{"PubChem":["11110652","124878320","144203596","170466274","4253808","50106880","8139976","85230868","90341376"],"drugbank":["DB02823"],"chEBI":["15732"]},"childChemblIds":["CHEMBL136061","CHEMBL2028559","CHEMBL3989828"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL514794","canonicalSmiles":"Cc1cc(CNC(=O)c2cc(C(=O)NCc3ccc(F)c(C)c3)ncn2)ccc1F","inchiKey":"PYFRREJCFXFNRR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL514794","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04760"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL53","canonicalSmiles":"CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3","inchiKey":"VMWNQDUVQKEIOC-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APOMORPHINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["6a.beta.-aporphine-10,11-diol","APL-130277","Apomorphine","Apomorphinum","VR-040","VR040"],"crossReferences":{"DailyMed":["apomorphine%20hydrochloride"],"PubChem":["11114270","144204518","170465297","26752261"],"Wikipedia":["Apomorphine"],"drugbank":["DB00714"],"chEBI":["48538"]},"childChemblIds":["CHEMBL3187985","CHEMBL1256708","CHEMBL1616"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000069696","ENSG00000151577"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0005180","EFO_0004234","HP_0003419","MONDO_0043510","MONDO_0007079","EFO_0003882","HP_0000738"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for parkinson disease and erectile dysfunction and has 5 investigational indications."}
{"id":"CHEMBL549695","canonicalSmiles":"Cc1ccc(N)cc1C(=O)N[C@H](C)c1cccc2ccccc12","inchiKey":"UVERBUNNCOKGNZ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549695","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08656"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559147","canonicalSmiles":"C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1","inchiKey":"IYOZTVGMEWJPKR-IJLUTSLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Y-27632","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Y-27632"],"crossReferences":{"PubChem":["26753164","26753165"],"drugbank":["DB08756"],"chEBI":["75393"]},"childChemblIds":["CHEMBL1605605"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL559362","canonicalSmiles":"Br.O=C(CC1NCCCC1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O","inchiKey":"SJUWEPZBTXEUMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HALOFUGINONE HYDROBROMIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1197091","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Stenorol"],"synonyms":["Halofuginone hbr","Halofuginone hydrobromide","NSC-713205","RU-19110"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL56279","canonicalSmiles":"N#CN","inchiKey":"XZMCDFZZKTWFGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYANAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cyanamide"],"crossReferences":{"PubChem":["144210995","26757797"],"Wikipedia":["Cyanamide"],"drugbank":["DB02679"],"chEBI":["16698"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566","canonicalSmiles":"O=c1cc[nH]c(=O)[nH]1","inchiKey":"ISAKRJDGNUQOIC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URACIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-205603-01","Fluorouracil specified compound c","Hybar x","Lamivudine impurity e","Lamivudine impurity e rs","NSC-3970","Pyrod","SQ-6201","SQ-7726","SQ-8493","Uracil"],"crossReferences":{"PubChem":["144208221","170465915","51088798","70371"],"Wikipedia":["Uracil"],"drugbank":["DB03419"],"chEBI":["17568"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL59","canonicalSmiles":"NCCc1ccc(O)c(O)c1","inchiKey":"VYFYYTLLBUKUHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOPAMINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A-dopamine","Carbilev","Dobutamine a","Dopamine","Intropin","Medopa","NSC-173182","Oxytyramine","Parcopa","Sinemet"],"crossReferences":{"DailyMed":["dopamine%20hydrochloride"],"PubChem":["104171172","11111282","124880336","124880337","124880340","144203718","170464942","26750067","26753786","26753787","50107800","57288369","90341661"],"Wikipedia":["Dopamine"],"drugbank":["DB00988"],"chEBI":["18243"]},"childChemblIds":["CHEMBL3247442","CHEMBL1557"],"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["MONDO_0002492","EFO_0006859","EFO_0006834","EFO_0005207","EFO_0000373","EFO_0000319","EFO_1002048","HP_0100806","HP_0100543","MONDO_0002050","EFO_1001485","MONDO_0005180","EFO_0003144","EFO_0000712","EFO_0003884","EFO_0000612","EFO_0003917","HP_0031273","EFO_0000400","EFO_0005251","EFO_1000899"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 4 approved and 9 investigational indications."}
{"id":"CHEMBL657","canonicalSmiles":"CN(C)CCOC(c1ccccc1)c1ccccc1","inchiKey":"ZZVUWRFHKOJYTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENHYDRAMINE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Antitussive","Beldin","Belix","Benadryl","Benylin","Dibenil","Diphen","Diphenhdyra","Diphenhydramine","Hydramine","Restamin","Silphen"],"crossReferences":{"DailyMed":["diphenhydramine%20citrate","diphenhydramine%20hydrochloride"],"PubChem":["104171144","11111059","11111060","124879862","124879863","144203678","170466857","26751623","50100219","50104292","85148365","90341811"],"Wikipedia":["Diphenhydramine"],"drugbank":["DB01075"],"chEBI":["4636"]},"childChemblIds":["CHEMBL1620","CHEMBL1201089"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","HP_0000989","MONDO_0002009","HP_0012735","EFO_0005592","EFO_0000681","EFO_1000657","EFO_0005952","EFO_0000540","EFO_0004698","HP_0002018","EFO_0007160","Orphanet_365","EFO_0000096","EFO_0002690","EFO_0000544","MONDO_0008903","EFO_0004208","EFO_1001904","EFO_0005854","EFO_0000198","EFO_0006928","EFO_0005761","MONDO_0004658","EFO_0000220","EFO_0000701","EFO_0009516","HP_0001742","EFO_0000384","MONDO_0008315","EFO_0004239","MP_0001845","EFO_0009688","MONDO_0044917","Orphanet_60","EFO_0000574","EFO_0001378","EFO_0009847","EFO_0003086","MONDO_0005090","HP_0000726","EFO_0005252","MONDO_0007254","MONDO_0005271","EFO_0000274","MONDO_0020657","MONDO_0001056","MONDO_0005277","EFO_0005531","EFO_1000783","MONDO_0002050","MONDO_0017287","HP_0002017","EFO_0006890","EFO_0003938","HP_0002013","MONDO_0007079","EFO_0005230","EFO_0007490","EFO_0000616","EFO_0008521","EFO_0000685","EFO_0003958","EFO_0000403","EFO_0000222","EFO_0003843","EFO_0003060","EFO_0007214","EFO_0004599","EFO_0000311","HP_0002315","EFO_0000095","EFO_0007359","MONDO_0011962","MONDO_0002367","EFO_0004270","EFO_0003956"],"count":77},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1946 and has 15 approved and 60 investigational indications."}
{"id":"CHEMBL6607","canonicalSmiles":"COc1cc(CC(C)N)c(OC)cc1Br","inchiKey":"FXMWUTGUCAKGQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROLAMFETAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brolamfetamine","J275.083J"],"crossReferences":{"Wikipedia":["2,5-Dimethoxy-4-bromoamphetamine"],"drugbank":["DB01484"]},"childChemblIds":["CHEMBL2355922"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL891","canonicalSmiles":"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12","inchiKey":"LQOLIRLGBULYKD-JKIFEVAISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOXACILLIN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orbenin"],"synonyms":["Cloxacillin","Cloxapen","Tegopen"],"crossReferences":{"Wikipedia":["Cloxacillin"],"drugbank":["DB01147"],"chEBI":["49566"]},"childChemblIds":["CHEMBL3989531","CHEMBL1200388","CHEMBL262636"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for bacterial disease and has 5 investigational indications."}
